Quiste odontogénico calcificante (quiste de Gorlin). Reporte de un caso y su seguimiento. Revisión de la literatura

dc.contributor.authorBenjamín Morales Trejo
dc.contributor.authorLuis Carbajal Bello
dc.coverage.spatialBolivia
dc.date.accessioned2026-03-22T16:45:54Z
dc.date.available2026-03-22T16:45:54Z
dc.date.issued1999
dc.descriptionCitaciones: 1
dc.description.abstractAtherosclerosis (AS) is a leading cause of the life-threatening cardiovascular disease (CVD), creating an urgent need for efficient, biocompatible therapeutics for diagnosis and treatment. Biomimetic nanomedicines (bNMs) are moving closer to fulfilling this need, pushing back the frontier of nano-based drug delivery systems design. This review seeks to outline how these nanomedicines (NMs) might work to diagnose and treat atherosclerosis, to trace the trajectory of their development to date and in the coming years, and to provide a foundation for further discussion about atherosclerotic theranostics.
dc.identifier.doi10.1016/j.apsb.2022.11.014
dc.identifier.urihttps://doi.org/10.1016/j.apsb.2022.11.014
dc.identifier.urihttps://andeanlibrary.org/handle/123456789/60171
dc.language.isoen
dc.sourceUniversidad La Salle
dc.subjectMedicine
dc.subjectLesion
dc.subjectEnucleation
dc.subjectAmeloblastoma
dc.subjectCyst
dc.subjectOdontogenic cyst
dc.subjectRadiography
dc.subjectPathology
dc.subjectAnatomy
dc.titleQuiste odontogénico calcificante (quiste de Gorlin). Reporte de un caso y su seguimiento. Revisión de la literatura
dc.typearticle

Files